12:00 AM
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

Aurum Biosciences, Oxygen Biotherapeutics deal

The companies partnered to develop a diagnostic and therapeutic to treat acute ischemic stroke using Oxygen's Oxycyte perfluorocarbon (PFC)-based therapeutic oxygen carrier in combination...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >